H

Heard

Your voice in democracy

Sign InJoin Heard
SB 140STATE · ColoradoIntroduced

Exempt Drugs from Prescription Drug Affordability Board Reviews

The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; orA licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

Voted: 4/22/2026Source

How representatives voted

16 yea·2 nay·2 other

Action history

  • 4/22/2026House Committee on Health & Human Services Postpone Indefinitely
  • 4/21/2026Introduced In House - Assigned to Health & Human Services
  • 4/13/2026Senate Third Reading Passed - No Amendments
  • 4/10/2026Senate Third Reading Laid Over to 04/13/2026 - No Amendments
  • 4/9/2026Senate Second Reading Passed - No Amendments
  • 4/8/2026Senate Second Reading Laid Over to 04/09/2026 - No Amendments
  • 4/2/2026Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole
  • 3/16/2026Introduced In Senate - Assigned to Health & Human Services